Octreotide in refractory functional epigastric pain with nutritional impairment - An open study

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 7, 1999, Pages 969-975

  Ducrotte, P ^a,b   Maillot, C ^a   Leroi, A M ^a   Lalaude, O ^a   Colin, R ^a   Denis, P ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; FOOD INTAKE; HUMAN; MALE; NAUSEA; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; RATING SCALE; SUBCUTANEOUS DRUG ADMINISTRATION; SYMPTOM; TREATMENT FAILURE; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; AGED; CHRONIC DISEASE; DEGLUTITION DISORDERS; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; OCTREOTIDE; PAIN, INTRACTABLE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 0033066328     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00541.x     Document Type: Article

References (23)

1. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990; 99: 1688-1704.
2. Bueno L, Fioramonti J, Delvaux M, Frexinos J. Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997; 112: 1714-43.
3. Randic M, Miletic V. Depressant actions of methionine-enkephalin and somatostatin in the cat dorsal born neurones activated by noxious stimuli. Brain Res 1978; 152: 196-202.
4. Bean BP. Neurotransmitter inhibition of neuronal calcium currents by change in channel voltage dependance. Nature 1989; 340: 153-6.
5. Murase K, Nedeljkov V, Randic M. The actions of neuropeptides on dorsal horn neurons in the rat spinal cord slice preparation: an intra cellular study. Brain Res 1982; 234: 170-6.
6. Madrazo I, Franco-Bourland RE, Leon-Maza M, Mena I. Intraventricular somatostatin-14 arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain. Appl Neurophysiol 1987; 50: 427-31.
7. Penn RD, Paice JA, Kroin JJ. Octreotide: a potent new nonopiate analgesic for intrathecal infusion. Pain 1992; 49: 13-19.
8. Sicuteri F, Geppetti P, Marabini S, Lembeck F. Pain relief by somatostatin in attacks of cluster headache. Pain 1984; 18: 359-65.
9. Talley NJ, Turner I, Middleton WR. Somatostatin and symptomatic relief on irritable bowel syndrome (letter). Lancet 1987; 2: 1144.
10. Hasler WH, Soudah H, Owyang C. A somatostatin analog inhibits afferent pathways mediating perception of rectal distension. Gastroenterology 1993; 104: 1390-7.
11. Bradette M, delvaux M, Staumont G, Fioramonti J, Bueno I, Frexinos J. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci 1994; 39: 1171-9.
12. Mertz H, Walsh H, Sytnik B, Mayer EA. The effect of octreotide on human gastric compliance and sensory perception. Neurogastroenterol Motil 1995; 7: 175-85.
13. Mearadji B, Straathof JWA, Biemond I, Lamers CBHW, Masclee AAM. Effects of somatostatin on proximal gastric motor function and visceral perception. Aliment Pharmacol Ther 1998; 12: 1163-9.
14. Neri M, Cuccurullo F, Marzio L. Effect of somatostatin on gallbladder volume and small intestinal motor activity in humans. Gastroenterology 1990; 98: 316-21.
15. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain 1985; 22: 1-31.
16. Crean GP, Holden RJ, Knill-Jones RP, et al. A database on dyspepsia. Gut 1994; 35: 191-202.
17. Talley NJ, Boyce P, Franz CP, Jones M. Dyspepsia and health care seeking in a community. How important are psychological factors? Dig Dis Sci 1998; 43: 1016-22.
18. Holtmann G, Talley NJ. Functional dyspepsia. Current treatment recommendations. Drugs 1993; 45: 918-30.
19. Brunner H, the Austro-Cis Study Group. Factors affecting dose selection and outcome of cisapride treatment for dyspepsia in primary care. Aliment Pharmacol Ther 1996; 10: 587-94.
20. Talley NJ. Functional dyspepsia: should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107-15.
21. Prakash C, Lutsman PJ, Freedland KE, Clouse RE. Tricyclic antidepressants for functional nausea and vomiting. Clinical outcome in 37 patients. Dig Dis Sci 1998; 43: 1951-6.
22. Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional organic disorders. Gut 1994; 35: 1064-9.
23. Owyang C. Octreotide in gastrointestinal motility disorders. Gut 1994; 35(Suppl.): 11-14.